Overview of the OxyTC Trial and Its Methodology

This chapter examines the OxyTC trial, initiated in 2013, and its connections to the Boost2 study, showcasing advancements in medical understanding. It highlights the trial's multi-site, open-label design and the critical inclusion and exclusion criteria that shaped participant selection to ensure a relevant study population.